TipRanks
Advertisement

IMCV - ETF AI Analysis

Compare

Top Page

IMCV

iShares Morningstar Mid-Cap ETF (IMCV)

Rating:70Neutral
Price Target:―
IMCV, the iShares Morningstar Mid-Cap ETF, has a solid overall rating driven by strong, diversified holdings like Travelers Companies and Elevance Health, which bring robust financial performance, attractive valuations, and positive growth outlooks to the portfolio. Financials such as US Bancorp and PNC also support the rating with good earnings and reasonable valuations, though names like 3M and Mondelez, facing profitability, leverage, and bearish technical trends, weigh on the fund. The main risk factor is the ETF’s meaningful exposure to cyclical sectors like energy and financials, which can increase sensitivity to economic and market swings.
Positive Factors
Strong Recent Performance
The ETF has delivered solid gains so far this year and in recent months, showing positive momentum for investors.
Low Expense Ratio
The fund’s relatively low fee means more of the investment returns stay in investors’ pockets instead of going to costs.
Broad Sector Diversification
Holdings are spread across many sectors, which helps reduce the impact if any single industry runs into trouble.
Negative Factors
Heavy U.S. Concentration
Almost all of the fund’s assets are invested in U.S. companies, offering limited diversification across global markets.
Sector Tilts Toward Financials and Energy
Large weights in financial and energy stocks mean the ETF could be more sensitive to downturns in those specific sectors.
Mixed Performance Among Top Holdings
While several top positions have shown strong gains, at least one major holding has been weak, which can drag on overall results.

IMCV vs. SPDR S&P 500 ETF (SPY)

IMCV Summary

The iShares Morningstar Mid-Cap ETF (IMCV) follows the Morningstar US Mid Cap Broad Value Index, focusing on mid-sized U.S. companies that appear undervalued. It spreads your money across many sectors like financials, energy, and health care, with well-known holdings such as PNC Financial, US Bancorp, 3M, and UPS. Investors might consider IMCV for diversification and the potential long-term growth of solid mid-sized businesses bought at attractive prices. A key risk is that mid-cap value stocks can still go up and down with the overall stock market, so your investment value may fluctuate.
How much will it cost me?The iShares Morningstar Mid-Cap ETF (IMCV) has an expense ratio of 0.06%, which means you’ll pay $0.60 per year for every $1,000 invested. This is lower than average because it’s a passively managed ETF that tracks an index, keeping costs down for investors.
What would affect this ETF?The iShares Morningstar Mid-Cap ETF (IMCV) could benefit from economic growth in the U.S., as mid-cap companies often thrive during periods of expansion due to their balance of growth potential and stability. Positive trends in sectors like financials, technology, and energy, which have significant weight in the ETF, could also drive performance. However, rising interest rates or economic slowdowns may negatively impact mid-cap value stocks, particularly those in interest-sensitive sectors like utilities and real estate.

IMCV Top 10 Holdings

IMCV is powered by a mix of U.S. mid-cap value names, with energy and financials steering the ship. Refiners like Valero and Phillips 66 have been rising steadily, giving the fund a strong tailwind from the energy patch, while Schlumberger adds a more mixed but still supportive oilfield angle. On the financial side, PNC and US Bancorp have been generally constructive, though their recent wobble means they’re not full-speed ahead. Health care is in the mix too, with Regeneron’s strong momentum helping offset more cautious, steady contributors like Elevance and Mondelez.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Valero Energy1.59%$17.93M$108.59B119.50%
69
Neutral
Automatic Data Processing1.51%$17.03M$107.12B-8.92%
70
Outperform
Phillips 661.47%$16.62M$102.46B83.97%
73
Outperform
US Bancorp1.31%$14.81M$92.61B18.12%
76
Outperform
PNC Financial1.29%$14.51M$90.94B10.16%
71
Outperform
3M1.25%$14.09M$87.31B9.63%
59
Neutral
Hewlett Packard Enterprise1.22%$13.75M$81.02B162.37%
68
Neutral
Elevance Health1.21%$13.58M$87.27B25.00%
76
Outperform
Regeneron1.14%$12.80M$82.77B43.30%
78
Outperform
Mondelez International1.12%$12.67M$77.96B-2.72%
62
Neutral

IMCV Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price―
Price Trends
50DMA
95.77
Negative
100DMA
92.84
Positive
200DMA
88.80
Positive
Market Momentum
MACD
-0.76
Positive
RSI
36.00
Neutral
STOCH
7.35
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IMCV, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 95.32, equal to the 50-day MA of 95.77, and equal to the 200-day MA of 88.80, indicating a neutral trend. The MACD of -0.76 indicates Positive momentum. The RSI at 36.00 is Neutral, neither overbought nor oversold. The STOCH value of 7.35 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IMCV.

IMCV Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
――$1.13B0.06%
70
Neutral
――$8.50B0.18%
69
Neutral
――$8.14B0.23%
69
Neutral
――$7.02B0.34%
71
Outperform
――$2.74B0.15%
70
Neutral
――$1.24B0.10%
69
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IMCV
iShares Morningstar Mid-Cap ETF
93.30
14.85
18.93%
IJJ
iShares S&P Mid-Cap 400 Value ETF
―
―
―
FMDE
Fidelity Enhanced Mid Cap ETF
―
―
―
XMMO
Invesco S&P MidCap Momentum ETF
―
―
―
MDYV
SPDR S&P 400 Mid Cap Value ETF
―
―
―
IVOV
Vanguard S&P Mid-Cap 400 Value ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement